XML 40 R29.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Condensed Consolidating Financial Information (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2018
Condensed Financial Information of Parent Company Only Disclosure [Abstract] |
Condensed Consolidating Statement of Operations |
| Three Months Ended March 31, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 5.4 |  |  | $ | 587.0 |  |  | $ | 486.2 |  |  | $ | (32.6 | ) |  | $ | 1,046.0 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 13.2 |  |  | 279.2 |  |  | 283.2 |  |  | (5.4 | ) |  | 570.2 |
Other operating expenses | 8.4 |  |  | 83.7 |  |  | 61.5 |  |  | (12.4 | ) |  | 141.2 |
Occupancy costs | 0.5 |  |  | 23.7 |  |  | 9.2 |  |  | (14.8 | ) |  | 18.6 |
Supplies | — |  |  | 24.4 |  |  | 15.5 |  |  | — |  |  | 39.9 |
General and administrative expenses | 39.4 |  |  | — |  |  | 21.7 |  |  | — |  |  | 61.1 |
Depreciation and amortization | 2.0 |  |  | 26.1 |  |  | 17.8 |  |  | — |  |  | 45.9 |
Total operating expenses | 63.5 |  |  | 437.1 |  |  | 408.9 |  |  | (32.6 | ) |  | 876.9 |
Interest expense and amortization of debt discounts and fees | 29.8 |  |  | 5.2 |  |  | 5.7 |  |  | (5.1 | ) |  | 35.6 |
Other (income) loss | (4.7 | ) |  | (0.2 | ) |  | (0.1 | ) |  | 5.1 |  |  | 0.1 |
Equity in net income of nonconsolidated affiliates | — |  |  | (1.9 | ) |  | (0.4 | ) |  | — |  |  | (2.3 | )
Equity in net income of consolidated affiliates | (112.0 | ) |  | (17.8 | ) |  | — |  |  | 129.8 |  |  | — |
Management fees | (38.4 | ) |  | 28.4 |  |  | 10.0 |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 67.2 |  |  | 136.2 |  |  | 62.1 |  |  | (129.8 | ) |  | 135.7 |
Provision for income tax (benefit) expense | (17.1 | ) |  | 36.7 |  |  | 10.4 |  |  | — |  |  | 30.0 |
Income from continuing operations | 84.3 |  |  | 99.5 |  |  | 51.7 |  |  | (129.8 | ) |  | 105.7 |
Loss from discontinued operations, net of tax | (0.5 | ) |  | — |  |  | — |  |  | — |  |  | (0.5 | )
Net income | 83.8 |  |  | 99.5 |  |  | 51.7 |  |  | (129.8 | ) |  | 105.2 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (21.4 | ) |  | — |  |  | (21.4 | )
Net income attributable to Encompass Health | $ | 83.8 |  |  | $ | 99.5 |  |  | $ | 30.3 |  |  | $ | (129.8 | ) |  | $ | 83.8 |
Comprehensive income | $ | 83.8 |  |  | $ | 99.5 |  |  | $ | 51.7 |  |  | $ | (129.8 | ) |  | $ | 105.2 |
Comprehensive income attributable to Encompass Health | $ | 83.8 |  |  | $ | 99.5 |  |  | $ | 30.3 |  |  | $ | (129.8 | ) |  | $ | 83.8 |
| Three Months Ended March 31, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 5.3 |  |  | $ | 560.7 |  |  | $ | 422.3 |  |  | $ | (31.2 | ) |  | $ | 957.1 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 11.2 |  |  | 270.3 |  |  | 253.9 |  |  | (5.3 | ) |  | 530.1 |
Other operating expenses | 8.2 |  |  | 76.9 |  |  | 54.6 |  |  | (11.9 | ) |  | 127.8 |
Occupancy costs | 0.5 |  |  | 23.3 |  |  | 8.1 |  |  | (14.0 | ) |  | 17.9 |
Supplies | — |  |  | 23.5 |  |  | 13.5 |  |  | — |  |  | 37.0 |
General and administrative expenses | 31.6 |  |  | — |  |  | 4.9 |  |  | — |  |  | 36.5 |
Depreciation and amortization | 2.4 |  |  | 25.7 |  |  | 17.1 |  |  | — |  |  | 45.2 |
Total operating expenses | 53.9 |  |  | 419.7 |  |  | 352.1 |  |  | (31.2 | ) |  | 794.5 |
Interest expense and amortization of debt discounts and fees | 35.2 |  |  | 5.4 |  |  | 5.8 |  |  | (5.1 | ) |  | 41.3 |
Other income | (5.4 | ) |  | (0.1 | ) |  | (0.6 | ) |  | 5.1 |  |  | (1.0 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (1.9 | ) |  | (0.2 | ) |  | — |  |  | (2.1 | )
Equity in net income of consolidated affiliates | (86.2 | ) |  | (9.8 | ) |  | — |  |  | 96.0 |  |  | — |
Management fees | (35.9 | ) |  | 27.1 |  |  | 8.8 |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 43.7 |  |  | 120.3 |  |  | 56.4 |  |  | (96.0 | ) |  | 124.4 |
Provision for income tax (benefit) expense | (23.4 | ) |  | 48.0 |  |  | 15.1 |  |  | — |  |  | 39.7 |
Income from continuing operations | 67.1 |  |  | 72.3 |  |  | 41.3 |  |  | (96.0 | ) |  | 84.7 |
Loss from discontinued operations, net of tax | (0.3 | ) |  | — |  |  | — |  |  | — |  |  | (0.3 | )
Net income | 66.8 |  |  | 72.3 |  |  | 41.3 |  |  | (96.0 | ) |  | 84.4 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (17.6 | ) |  | — |  |  | (17.6 | )
Net income attributable to Encompass Health | $ | 66.8 |  |  | $ | 72.3 |  |  | $ | 23.7 |  |  | $ | (96.0 | ) |  | $ | 66.8 |
Comprehensive income | $ | 67.1 |  |  | $ | 72.3 |  |  | $ | 41.3 |  |  | $ | (96.0 | ) |  | $ | 84.7 |
Comprehensive income attributable to Encompass Health | $ | 67.1 |  |  | $ | 72.3 |  |  | $ | 23.7 |  |  | $ | (96.0 | ) |  | $ | 67.1 |
Condensed Consolidating Balance Sheet |
| As of March 31, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Assets |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 69.0 |  |  | $ | 2.8 |  |  | $ | 14.6 |  |  | $ | — |  |  | $ | 86.4 |
Restricted cash | — |  |  | — |  |  | 69.4 |  |  | — |  |  | 69.4 |
Accounts receivable | — |  |  | 276.9 |  |  | 186.2 |  |  | — |  |  | 463.1 |
Other current assets | 81.7 |  |  | 19.5 |  |  | 75.5 |  |  | (87.1 | ) |  | 89.6 |
Total current assets | 150.7 |  |  | 299.2 |  |  | 345.7 |  |  | (87.1 | ) |  | 708.5 |
Property and equipment, net | 119.0 |  |  | 1,003.5 |  |  | 431.8 |  |  | — |  |  | 1,554.3 |
Goodwill | — |  |  | 854.6 |  |  | 1,118.5 |  |  | — |  |  | 1,973.1 |
Intangible assets, net | 11.7 |  |  | 103.8 |  |  | 280.6 |  |  | — |  |  | 396.1 |
Deferred income tax assets | 96.9 |  |  | 8.4 |  |  | 5.4 |  |  | (42.2 | ) |  | 68.5 |
Other long-term assets | 49.6 |  |  | 97.6 |  |  | 91.9 |  |  | — |  |  | 239.1 |
Intercompany notes receivable | 463.6 |  |  | — |  |  | — |  |  | (463.6 | ) |  | — |
Intercompany receivable and investments in consolidated affiliates | 2,860.0 |  |  | 413.5 |  |  | — |  |  | (3,273.5 | ) |  | — |
Total assets | $ | 3,751.5 |  |  | $ | 2,780.6 |  |  | $ | 2,273.9 |  |  | $ | (3,866.4 | ) |  | $ | 4,939.6 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | 32.8 |  |  | $ | 7.6 |  |  | $ | 9.8 |  |  | $ | (17.5 | ) |  | $ | 32.7 |
Accounts payable | 12.2 |  |  | 44.2 |  |  | 26.7 |  |  | — |  |  | 83.1 |
Accrued expenses and other current liabilities | 217.4 |  |  | 73.4 |  |  | 235.0 |  |  | (69.6 | ) |  | 456.2 |
Total current liabilities | 262.4 |  |  | 125.2 |  |  | 271.5 |  |  | (87.1 | ) |  | 572.0 |
Long-term debt, net of current portion | 2,261.7 |  |  | 240.2 |  |  | 42.5 |  |  | — |  |  | 2,544.4 |
Intercompany notes payable | — |  |  | — |  |  | 463.6 |  |  | (463.6 | ) |  | — |
Other long-term liabilities | 30.4 |  |  | 17.6 |  |  | 178.3 |  |  | (42.5 | ) |  | 183.8 |
Intercompany payable | — |  |  | — |  |  | 99.4 |  |  | (99.4 | ) |  | — |
| 2,554.5 |  |  | 383.0 |  |  | 1,055.3 |  |  | (692.6 | ) |  | 3,300.2 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |
Redeemable noncontrolling interests | — |  |  | — |  |  | 198.6 |  |  | — |  |  | 198.6 |
Shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Encompass Health shareholders’ equity | 1,197.0 |  |  | 2,397.6 |  |  | 776.2 |  |  | (3,173.8 | ) |  | 1,197.0 |
Noncontrolling interests | — |  |  | — |  |  | 243.8 |  |  | — |  |  | 243.8 |
Total shareholders’ equity | 1,197.0 |  |  | 2,397.6 |  |  | 1,020.0 |  |  | (3,173.8 | ) |  | 1,440.8 |
Total liabilities and shareholders’ equity | $ | 3,751.5 |  |  | $ | 2,780.6 |  |  | $ | 2,273.9 |  |  | $ | (3,866.4 | ) |  | $ | 4,939.6 |
| As of December 31, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Assets |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 17.2 |  |  | $ | — |  |  | $ | 54.4 |
Restricted cash | — |  |  | — |  |  | 62.4 |  |  | — |  |  | 62.4 |
Accounts receivable | — |  |  | 285.2 |  |  | 186.9 |  |  | — |  |  | 472.1 |
Other current assets | 61.4 |  |  | 21.7 |  |  | 48.7 |  |  | (18.5 | ) |  | 113.3 |
Total current assets | 95.7 |  |  | 309.8 |  |  | 315.2 |  |  | (18.5 | ) |  | 702.2 |
Property and equipment, net | 101.8 |  |  | 991.5 |  |  | 423.8 |  |  | — |  |  | 1,517.1 |
Goodwill | — |  |  | 854.6 |  |  | 1,118.0 |  |  | — |  |  | 1,972.6 |
Intangible assets, net | 11.8 |  |  | 105.1 |  |  | 286.2 |  |  | — |  |  | 403.1 |
Deferred income tax assets | 97.4 |  |  | 8.4 |  |  | — |  |  | (42.2 | ) |  | 63.6 |
Other long-term assets | 49.2 |  |  | 100.5 |  |  | 85.4 |  |  | — |  |  | 235.1 |
Intercompany notes receivable | 486.2 |  |  | — |  |  | — |  |  | (486.2 | ) |  | — |
Intercompany receivable and investments in consolidated affiliates | 2,839.1 |  |  | 311.3 |  |  | — |  |  | (3,150.4 | ) |  | — |
Total assets | $ | 3,681.2 |  |  | $ | 2,681.2 |  |  | $ | 2,228.6 |  |  | $ | (3,697.3 | ) |  | $ | 4,893.7 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | 32.8 |  |  | $ | 7.4 |  |  | $ | 9.6 |  |  | $ | (17.5 | ) |  | $ | 32.3 |
Accounts payable | 10.4 |  |  | 43.5 |  |  | 24.5 |  |  | — |  |  | 78.4 |
Accrued expenses and other current liabilities | 166.8 |  |  | 82.0 |  |  | 159.0 |  |  | (1.0 | ) |  | 406.8 |
Total current liabilities | 210.0 |  |  | 132.9 |  |  | 193.1 |  |  | (18.5 | ) |  | 517.5 |
Long-term debt, net of current portion | 2,258.5 |  |  | 242.2 |  |  | 44.7 |  |  | — |  |  | 2,545.4 |
Intercompany notes payable | — |  |  | — |  |  | 486.2 |  |  | (486.2 | ) |  | — |
Other long-term liabilities | 31.0 |  |  | 17.8 |  |  | 178.6 |  |  | (42.1 | ) |  | 185.3 |
Intercompany payable | — |  |  | — |  |  | 144.8 |  |  | (144.8 | ) |  | — |
| 2,499.5 |  |  | 392.9 |  |  | 1,047.4 |  |  | (691.6 | ) |  | 3,248.2 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |
Redeemable noncontrolling interests | — |  |  | — |  |  | 220.9 |  |  | — |  |  | 220.9 |
Shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Encompass Health shareholders’ equity | 1,181.7 |  |  | 2,288.3 |  |  | 717.4 |  |  | (3,005.7 | ) |  | 1,181.7 |
Noncontrolling interests | — |  |  | — |  |  | 242.9 |  |  | — |  |  | 242.9 |
Total shareholders’ equity | 1,181.7 |  |  | 2,288.3 |  |  | 960.3 |  |  | (3,005.7 | ) |  | 1,424.6 |
Total liabilities and shareholders’ equity | $ | 3,681.2 |  |  | $ | 2,681.2 |  |  | $ | 2,228.6 |  |  | $ | (3,697.3 | ) |  | $ | 4,893.7 |
Condensed Consolidating Statement of Cash Flows |
| Three Months Ended March 31, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash provided by operating activities | $ | 10.5 |  |  | $ | 112.3 |  |  | $ | 93.5 |  |  | $ | — |  |  | $ | 216.3 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchases of property and equipment | (12.3 | ) |  | (31.4 | ) |  | (16.2 | ) |  | — |  |  | (59.9 | )
Acquisitions of businesses, net of cash acquired | — |  |  | — |  |  | (0.6 | ) |  | — |  |  | (0.6 | )
Proceeds from repayment of intercompany note receivable | 22.0 |  |  | — |  |  | — |  |  | (22.0 | ) |  | — |
Other, net | (5.1 | ) |  | (0.1 | ) |  | 5.1 |  |  | — |  |  | (0.1 | )
Net cash provided by (used in) investing activities | 4.6 |  |  | (31.5 | ) |  | (11.7 | ) |  | (22.0 | ) |  | (60.6 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal payments on intercompany note payable | — |  |  | — |  |  | (22.0 | ) |  | 22.0 |  |  | — |
Borrowings on revolving credit facility | 95.0 |  |  | — |  |  | — |  |  | — |  |  | 95.0 |
Payments on revolving credit facility | (95.0 | ) |  | — |  |  | — |  |  | — |  |  | (95.0 | )
Dividends paid on common stock | (25.3 | ) |  | — |  |  | (0.1 | ) |  | — |  |  | (25.4 | )
Purchase of equity interests in consolidated affiliates | (65.1 | ) |  | — |  |  | — |  |  | — |  |  | (65.1 | )
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (15.4 | ) |  | — |  |  | (15.4 | )
Other, net | (5.1 | ) |  | (1.8 | ) |  | (3.9 | ) |  | — |  |  | (10.8 | )
Change in intercompany advances | 115.1 |  |  | (79.1 | ) |  | (36.0 | ) |  | — |  |  | — |
Net cash provided by (used in) financing activities | 19.6 |  |  | (80.9 | ) |  | (77.4 | ) |  | 22.0 |  |  | (116.7 | )
Increase (decrease) in cash, cash equivalents, and restricted cash | 34.7 |  |  | (0.1 | ) |  | 4.4 |  |  | — |  |  | 39.0 |
Cash, cash equivalents, and restricted cash at beginning of period | 34.3 |  |  | 2.9 |  |  | 79.6 |  |  | — |  |  | 116.8 |
Cash, cash equivalents, and restricted cash at end of period | $ | 69.0 |  |  | $ | 2.8 |  |  | $ | 84.0 |  |  | $ | — |  |  | $ | 155.8 |
Reconciliation of Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |  |
Cash and cash equivalents at beginning of period | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 17.2 |  |  | $ | — |  |  | $ | 54.4 |
Restricted cash at beginning of period | — |  |  | — |  |  | 62.4 |  |  | — |  |  | 62.4 |
Cash, cash equivalents, and restricted cash at beginning of period | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 79.6 |  |  | $ | — |  |  | $ | 116.8 |
Cash and cash equivalents at end of period | $ | 69.0 |  |  | $ | 2.8 |  |  | $ | 14.6 |  |  | $ | — |  |  | $ | 86.4 |
Restricted cash at end of period | — |  |  | — |  |  | 69.4 |  |  | — |  |  | 69.4 |
Cash, cash equivalents, and restricted cash at end of period | $ | 69.0 |  |  | $ | 2.8 |  |  | $ | 84.0 |  |  | $ | — |  |  | $ | 155.8 |
| Three Months Ended March 31, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash provided by operating activities | $ | 45.1 |  |  | $ | 72.1 |  |  | $ | 63.6 |  |  | $ | — |  |  | $ | 180.8 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchases of property and equipment | (5.2 | ) |  | (12.9 | ) |  | (23.1 | ) |  | — |  |  | (41.2 | )
Acquisitions of businesses, net of cash acquired | (10.9 | ) |  | — |  |  | (5.5 | ) |  | — |  |  | (16.4 | )
Proceeds from repayment of intercompany note receivable | 7.0 |  |  | — |  |  | — |  |  | (7.0 | ) |  | — |
Other, net | (3.8 | ) |  | 8.8 |  |  | 3.5 |  |  | — |  |  | 8.5 |
Net cash used in investing activities | (12.9 | ) |  | (4.1 | ) |  | (25.1 | ) |  | (7.0 | ) |  | (49.1 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal payments on intercompany note payable | — |  |  | — |  |  | (7.0 | ) |  | 7.0 |  |  | — |
Borrowings on revolving credit facility | 55.0 |  |  | — |  |  | — |  |  | — |  |  | 55.0 |
Payments on revolving credit facility | (122.0 | ) |  | — |  |  | — |  |  | — |  |  | (122.0 | )
Repurchases of common stock, including fees and expenses | (18.1 | ) |  | — |  |  | — |  |  | — |  |  | (18.1 | )
Dividends paid on common stock | (22.2 | ) |  | — |  |  | — |  |  | — |  |  | (22.2 | )
Proceeds from exercising stock warrants | 26.6 |  |  | — |  |  | — |  |  | — |  |  | 26.6 |
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (11.5 | ) |  | — |  |  | (11.5 | )
Other, net | (12.0 | ) |  | (1.6 | ) |  | (0.5 | ) |  | — |  |  | (14.1 | )
Change in intercompany advances | 82.3 |  |  | (65.4 | ) |  | (16.9 | ) |  | — |  |  | — |
Net cash used in financing activities | (10.4 | ) |  | (67.0 | ) |  | (35.9 | ) |  | 7.0 |  |  | (106.3 | )
Increase in cash, cash equivalents, and restricted cash | 21.8 |  |  | 1.0 |  |  | 2.6 |  |  | — |  |  | 25.4 |
Cash, cash equivalents, and restricted cash at beginning of period | 20.6 |  |  | 1.6 |  |  | 79.2 |  |  | — |  |  | 101.4 |
Cash, cash equivalents, and restricted cash at end of period | $ | 42.4 |  |  | $ | 2.6 |  |  | $ | 81.8 |  |  | $ | — |  |  | $ | 126.8 |
Reconciliation of Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |  |
Cash and cash equivalents at beginning of period | $ | 20.6 |  |  | $ | 1.6 |  |  | $ | 18.3 |  |  | $ | — |  |  | $ | 40.5 |
Restricted cash at beginning of period | — |  |  | — |  |  | 60.9 |  |  | — |  |  | 60.9 |
Cash, cash equivalents, and restricted cash at beginning of period | $ | 20.6 |  |  | $ | 1.6 |  |  | $ | 79.2 |  |  | $ | — |  |  | $ | 101.4 |
Cash and cash equivalents at end of period | $ | 42.4 |  |  | $ | 2.6 |  |  | $ | 16.2 |  |  | $ | — |  |  | $ | 61.2 |
Restricted cash at end of period | — |  |  | — |  |  | 65.6 |  |  | — |  |  | 65.6 |
Cash, cash equivalents, and restricted cash at end of period | $ | 42.4 |  |  | $ | 2.6 |  |  | $ | 81.8 |  |  | $ | — |  |  | $ | 126.8 |

X
- References No definition available. + Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration